Nuclear localization of heme oxygenase-1 is associated with tumor progression of head and neck squamous cell carcinomas

Experimental and Molecular Pathology

Volumn 93, Issue 2, 2012, Pages 237-245

  Gandini, Norberto A ^a   Fermento, María E ^a   Salomón, Débora G ^a   Blasco, Jorge ^b   Patel, Vyomesh ^c   Gutkind, J Silvio ^c   Molinolo, Alfredo A ^c   Facchinetti, María M ^a   Curino, Alejandro C ^a  

^a Instituto de Investigaciones Bioquimicas Bahia Blanca   (Argentina)

^b Hospital Interzonal Dr Jose Penna   (Argentina)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Head and neck cancer; Heme oxygenase 1; Tissue microarray

Indexed keywords

HEME OXYGENASE 1; HEMIN; MESSENGER RNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER TISSUE; CELL NUCLEUS; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME LOCALIZATION; FEMALE; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LASER CAPTURE MICRODISSECTION; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

AGED; ANIMALS; CARCINOMA, SQUAMOUS CELL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; HEAD AND NECK NEOPLASMS; HEME OXYGENASE-1; HUMANS; MALE; MICE; MIDDLE AGED; PARAFFIN EMBEDDING; POLYMERASE CHAIN REACTION; PROGNOSIS; RNA, MESSENGER; TISSUE ARRAY ANALYSIS;

EID: 84862177395     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2012.05.001     Document Type: Article

References (37)

1. Berberat P.O., Dambrauskas Z., Gulbinas A., Giese T., Giese N., Künzli B., Autschbach F., Meuer S., Büchler M.W., Friess H. Inhibition of heme oxygenase-1 increases responsiveness of pancreatic cancer cells to anticancer treatment. Clinical Cancer Research 2005, 11(10):3790-3798.
2. Chang K.W., Lee T.C., Yeh W.I., Chung M.Y., Liu C.J., Chi L.Y., Lin S.C. Polymorphism in heme oxygenase-1 (HO-1) promoter is related to the risk of oral squamous cell carcinoma occurring on male areca chewers. British Journal of Cancer 2004, 91(8):1551-1555.
3. Darwiche N., Ryscavage A., Perez-Lorenzo R., Wright L., Bae D.S., Hennings H., Yuspa S.H., Glick A.B. Expression profile of skin papillomas with high cancer risk displays a unique genetic signature that clusters with squamous cell carcinomas and predicts risk for malignant conversion. Oncogene 2007, 26(48):6885-6895.
4. De Matteis F., Dawson S.J., Pons N., Pipino S. Bilirubin and uroporphyrinogen oxidation by induced cytochrome P4501A and cytochrome P4502B. Role of polyhalogenated biphenyls of different configuration. Biochemical Pharmacology 2002, 63(4):615-624.
5. Deininger M.H., Meyermann R., Trautmann K., Duffner F., Grote E.H., Wickboldt J., Schluesener H.J. Heme oxygenase (HO)-1 expressing macrophages/microglial cells accumulate during oligodendroglioma progression. Brain Research 2000, 882(1-2):1-8.
6. Doi K., Akaike T., Fujii S., Tanaka S., Ikebe N., Beppu T., Shibahara S., Ogawa M., Maeda H. Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth. British Journal of Cancer 1999, 80(12):1945-1954.
7. Facchinetti M.M., Gandini N.A., Fermento M.E., Sterin-Speziale N.B., Ji Y., Patel V., Gutkind S.J., Rivadulla M.G., Curino A.C. The expression of sphingosine kinase-1 in head and neck carcinoma. Cells, Tissues, Organs 2010, 192(5):314-324.
8. Fermento M.E., Gandini N.A., Lang C.A., Perez J.E., Maturi H.V., Curino A.C., Facchinetti M.M. Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer. Experimental and Molecular Pathology 2010, 88(2):256-264.
9. Goodman A.I., Choudhury M., daSilva J.L., Schwartzman M.L., Abraham N.G. Overexpression of the heme oxygenase gene in renal cell carcinoma. Proceedings of the Society for Experimental Biology and Medicine 1997, 214:54-61.
10. Greene F.L., Page D.L., Fleming I.D., Fritz A., Balch C.M. AJCC Cancer Staging Manual 2002, New York, Springer. sixth ed.
11. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100(1):57-70.
12. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144(5):646-674.
13. Hara E., Takahashi K., Tominaga T., Kumabe T., Kayama T., Suzuki H., Fujita H., Yoshimoto T., Shirato K., Shibahara S. Expression of heme oxygenase and inducible nitric oxide synthase mRNA in human brain tumors. Biochemical and Biophysical Research Communications 1996, 224(1):153-158.
14. Hennings H., Shores R., Mitchell P., Spangler E.F., Yuspa S.H. Induction of papillomas with a high probability of conversion to malignancy. Carcinogenesis 1985, 6(11):1607-1610.
15. Hori R., Kashiba M., Toma T., Yachie A., Goda N., Makino N., Soejima A., Nagasawa T., Nakabayashi K., Suematsu M. Gene transfection of H25A mutant heme oxygenase-1 protects cells against hydroperoxide-induced cytotoxicity. Journal of Biological Chemistry 2002, 277(12):10712-10718.
16. Jemal A., Siegel R., Ward E., Hao Y., Xu J., Murray T., Thun M.J. Cancer statistics, 2008. CA: A Cancer Journal for Clinicians 2008, 58(2):71-96.
17. Jozkowicz A., Was H., Dulak J. Heme oxygenase-1 in tumors: is it a false friend?. Antioxidants & Redox Signaling 2007, 9(12):2099-2117.
18. Lee J., Lee S.K., Lee B.U., Lee H.J., Cho N.P., Yoon J.H., Choi H.R., Lee S.K., Kim E.C. Upregulation of heme oxygenase-1 in oral epithelial dysplasias. International Journal of Oral and Maxillofacial Surgery 2008, 37(3):287-292.
19. Lee S.S., Yang S.F., Tsai C.H., Chou M.C., Chou M.Y., Chang Y.C. Upregulation of heme oxygenase-1 expression in areca-quid-chewing-associated oral squamous cell carcinoma. Journal of the Formosan Medical Association 2008, 107(5):355-363.
20. Lin Q., Weis S., Yang G., Weng Y.H., Helston R., Rish K., Smith A., Bordner J., Polte T., Gaunitz F., Dennery P.A. Heme oxygenase-1 protein localizes to the nucleus and activates transcription factors important in oxidative stress. Journal of Biological Chemistry 2007, 282(28):20621-22033.
21. 2-??CT method. Methods 2001, 25(4):402-408.
22. Maines M.D., Abrahamsson P.A. Expression of heme oxygenase-1 (HSP32) in human prostate: normal, hyperplastic, and tumor tissue distribution. Urology 1996, 47(5):727-733.
23. Maines M.D., Gibbs P.E. 30 some years of heme oxygenase: from a "molecular wrecking ball" to a "mesmerizing" trigger of cellular events. Biochemical and Biophysical Research Communications 2005, 338(1):568-577.
24. Mayerhofer M., Florian S., Krauth M.T., Aichberger K.J., Bilban M., Marculescu R., Printz D., Fritsch G., Wagner O., Selzer E., Sperr W.R., Valent P., Sillaber C. Identification of heme oxygenase-1 as a novel BCR/ABL-dependent survival factor in chronic myeloid leukemia. Cancer Research 2004, 64(9):3148-3154.
25. McAllister S.C., Hansen S.G., Ruhl R.A., Raggo C.M., DeFilippis V.R., Greenspan D., Früh K., Moses A.V. Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 2004, 103(9):3465-3473.
26. Molinolo A.A., Hewitt S.M., Amornphimoltham P., Keelawat S., Rangdaeng S., Meneses García A., Raimondi A.R., Jufe R., Itoiz M., Gao Y., Saranath D., Kaleebi G.S., Yoo G.H., Leak L., Myers E.M., Shintani S., Wong D., Massey H.D., Yeudall W.A., Lonardo F., Ensley J., Gutkind J.S. Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clinical Cancer Research 2007, 13(17):4964-4973.
27. Otterbein L.E., Bach F.H., Alam J., Soares M., Tao Lu H., Wysk M., Davis R.J., Flavell R.A., Choi A.M. Carbon monoxide has anti-inflammatory effects involving the mitogen-activated protein kinase pathway. Nature Medicine 2000, 6(4):422-428.
28. Parkin D.M., Bray F., Ferlay J., Pisani P. Global cancer statistics, 2002. CA: A Cancer Journal for Clinicians 2005, 55(2):74-108.
29. Sacca P., Meiss R., Casas G., Mazza O., Calvo J.C., Navone N., Vazquez E. Nuclear translocation of haeme oxygenase-1 is associated to prostate cancer. British Journal of Cancer 2007, 97(12):1683-1689.
30. Schacter B.A., Kurz P. Alterations in hepatic and splenic microsomal electron transport system components, drug metabolism, heme oxygenase activity, and cytochrome P-450 turnover in Murphy-Sturm lymphosarcoma-bearing rats. Cancer Research 1982, 42(9):3557-3564.
31. Snyder S.H., Baranano D.E. Heme oxygenase: a font with multiple messengers. Neuropsychopharmacology 2001, 25(3):294-298.
32. Tenhunen R., Marver H.S., Schmid R. The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase. Proceedings of the National Academy of Sciences of the United States of America 1968, 61(2):748-755.
33. Torisu-Itakura H., Furue M., Kuwano M., Ono M. Co-expression of thymidine phosphorylase and heme oxygenase-1 in macrophages in human malignant vertical growth melanomas. Japanese Journal of Cancer Research 2000, 91(9):906-910.
34. Tsuji M.H., Yanagawa T., Iwasa S., Tabuchi K., Onizawa K., Bannai S., Toyooka H., Yoshida H. Heme oxygenase-1 expression in oral squamous cell carcinoma as involved in lymph node metastasis. Cancer Letters 1999, 138(1-2):53-59.
35. Was H., Dulak J., Jozkowickz A. Heme oxygenase-1 in tumor biology and therapy. Current Drug Targets 2010, 11(12):1551-15570.
36. Was H., Sokolowska M., Sierpniowska A., Dominik P., Skrzypek K., Lackowska B., Pratnicki A., Grochot-Przeczek A., Taha H., Kotlinowski J., Kozakowska M., Mazan A., Nowak W., Muchova L., Vitek L., Ratajska A., Dulak J., Jozkowicz A. Effects of heme oxygenase-1 on induction and development of chemically induced squamous cell carcinoma in mice. Free Radical Biology & Medicine 2011, 51(9):1717-1726. 10.1016/j.freeradbiomed.2011.07.025.
37. Yanagawa T., Omura K., Harada H., Nakaso K., Iwasa S., Koyama Y., Onizawa K., Yusa H., Yoshida H. Heme oxygenase-1 expression predicts cervical lymph node metastasis of tongue squamous cell carcinomas. Oral Oncology 2004, 40(1):21-27.